We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open998.9
High1,012.9
Low980.2
Prev. Close1,007.4
Avg. Traded Price998.84
Volume4,22,354

MARKET DEPTH

info2
Total bid621.00
Total ask0.00
OrdersQtyBid
66211007.4
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

980.209 hours ago
1,012.909 hours ago
arrow

LOWER/UPPER CIRCUITS

790.80
1,186.20
arrow
Alembic Pharmaceuticals Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 7.32%, in the last year to ₹6,714.63 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
notePrice to Earning Ratio,is 33.3, lower than its sector PE ratio of 42.18.
noteQuarterly Revenue,rose 16.66% YoY to ₹1,783.83 Cr. Its sector's average revenue growth YoY for the quarter was 11.44%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 12.86%
Net profit growth 5Y CAGR : 0.8%
Alembic Pharmaceuticals Limited is involved in manufacturing and marketing of India Formulations, International Generics, and Active Pharmaceutical Ingredients with vertical integration capabilities. Headquartered in Vadodara, Gujarat. It is the flagship company of the pioneering Alembic Group. Close to 40% of its revenues are generated from the US generics business, while 18% of its business comes from third-party API sales. The company’s capabilities also extend to making oral solid injectables in Oncology, general complex injectables and ophthalmology. The company’s manufacturing facility in Sikkim is dedicated for manufacturing its India Formulations.
personal

Grow your wealth with more research recommendations

+91